Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers

Journal of Alzheimer's Disease

Volumn 31, Issue 2, 2012, Pages 265-275

  Steenland, Kyle ^a,b   Karnes, Conny ^a   Seals, Ryan ^d   Carnevale, Claudine ^a,c   Hermida, Adriana ^b,c   Levey, Allan ^b,c  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alzheimer's disease; dementia; depression; mild cognitive impairment

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; APOLIPOPROTEIN E4; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DESVENLAFAXINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE MALEATE; IMIPRAMINE; MAPROTILINE; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PAZUFLOXACIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VENLAFAXINE;

ALLELE; ALZHEIMER DISEASE; ARTICLE; DEPRESSION; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; GERIATRIC DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHIATRIC INVENTORY QUESTIONNAIRE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; RISK FACTOR; UNITED STATES;

EID: 84865575134     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111922     Document Type: Article

References (42)

1. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10, 819-828.
2. Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Imbimbo BP, Santamato A, Vendemiale G, Seripa D, Pilotto A, Capurso A, Solfrizzi V (2010) Late-life depression, mild cognitive impairment, and dementia: Possible continuum?Am J Geriatr Psychiatry 18, 98-116.
3. Steffens DC, Fisher GG, Langa KM, Potter GG, Plassman BL (2009) Prevalence of depression among older Americans: The Aging, Demographics and Memory Study. Int Psychogeriatr 21, 879-888.
4. Kessler RC, Birnbaum H, Bromet E, Hwang I, Sampson N, ShahlyV(2010) Age differences in major depression: Results from the National Comorbidity Survey Replication (NCS-R). Psychol Med 40, 225-237.
5. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D (2006) Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63, 530-538.
6. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K (2006) Depressive symptoms, vascular disease, and mild cognitive impairment: Findings from the Cardiovascular Health Study. Arch Gen Psychiatry 63, 273-279.
7. Geda YE, Knopman DS, Mrazek DA, Jicha GA, Smith GE, Negash S, Boeve BF, Ivnik RJ, Petersen RC, Pankratz VS, Rocca WA (2006) Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment:Aprospective cohort study. Arch Neurol 63, 435-440.
8. Panza F, D'Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, Todarello O, Pellicani V, Santamato A, Scapicchio P, Maggi S, Scafato E, Gandin C, Capurso A, Solfrizzi V (2008) Italian Longitudinal Study on Aging Working Group. Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging. Dement Geriatr Cogn Disord 25, 336-346. (Pubitemid 351562955)
9. Wilson RS, Schneider JA, Boyle PA, Arnold SE, Tang Y, Bennett DA (2007) Chronic distress and incidence of mild cognitive impairment. Neurology 68, 2085-2092. (Pubitemid 46912126)
10. Goveas JS, Espeland MA,Woods NF,Wassertheil-Smoller S, Kotchen JM (2011) Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: TheWomen's Health Initiative Memory Study. J Am Geriatr Soc 59, 57-66.
11. Unverzagt FW, Ogunniyi A, Taler V, Gao S, Lane KA, Baiyewu O, Gureje O, Smith-Gamble V, Hake A, Hendrie HC, Hall KS (2011) Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans. Alzheimer Dis Assoc Disord 25, 4-10.
12. Ravaglia G, Forti P, Lucicesare A, Rietti E, Pisacane N, Mariani E, Dalmonte E (2008) Prevalent depressive symptoms as a risk factor for conversion to mild cognitive impairment in an elderly Italian cohort. Am J Geriatr Psychiatry 16, 834-843.
13. K̈ohler S, van Boxtel MP, van Os J, Thomas AJ, O'Brien JT, Jolles J, Verhey FR, Allardyce J (2010) Depressive symptoms and cognitive decline in community-dwelling older adults. J Am Geriatr Soc 58, 873-879.
14. Dotson VM, Beydoun MA, Zonderman AB (2010) Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75, 27-34.
15. Modrego PJ, Ferŕandez J (2004) Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type:Aprospective cohort study. Arch Neurol 61, 1290-1293. (Pubitemid 39062687)
16. Robert PH, Berr C, Volteau M, Bertogliati C, Benoit M, Sarazin M, Legrain S, Dubois B, PŕeAL study (2006) Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: A one-year follow-up study. Clin Neurol Neurosurg 108, 733-736. (Pubitemid 44709787)
17. Gabryelewicz T, Styczynska M, Luczywek E, Barczak A, Pfeffer A, Androsiuk W, Chodakowska-Zebrowska M, Wasiak B, Peplonska B, Barcikowska M (2007) The rate of conversion of mild cognitive impairment to dementia: Predictive role of depression. Int J Geriatr Psychiatry 22, 563-567. (Pubitemid 46951755)
18. Teng E, Lu PH, Cummings JL (2007) Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dement Geriatr Cogn Disord 24, 253-259. (Pubitemid 47482071)
19. Palmer K, Berger AK, Monastero R, Winblad B, B̈ackman L, Fratiglioni L (2007) Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 68, 1596-1602. (Pubitemid 46717984)
20. Panza F, Capurso C, D'Introno A, Colacicco AM, Zenzola A, Menga R, Pistoia G, Santamato A, Scafato E, Gandin C, Capurso A, SolfrizziV(2008) Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging. Int J Geriatr Psychiatry 23, 726-734.
21. Houde M, Bergman H, Whitehead V, Chertkow H (2008) A predictive depression pattern in mild cognitive impairment. Int J Geriatr Psychiatry 23, 1028-1033.
22. Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL (2009) Alzheimer's Disease Cooperative Study Group. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology 72, 2115-2121.
23. Vicini Chilovi B, Conti M, Zanetti M, Mazz̀u I, Rozzini L, Padovani A (2009) Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients. Dement Geriatr Cogn Disord 27, 390-398.
24. Edwards ER, Spira AP, Barnes DE,YaffeK(2009) Neuropsychiatric symptoms in mild cognitive impairment: Differences by subtype and progression to dementia. Int J Geriatr Psychiatry 24, 716-722.
25. Artero S, Ancelin ML, Portet F, Dupuy A, Berr C, Dartigues JF, Tzourio C, Rouaud O, Poncet M, Pasquier F, Auriacombe S,Touchon J, RitchieK(2008) Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry 79, 979-984.
26. Royall DR, Palmer R, Chiodo LK, Polk MJ (2012) Depressive symptoms predict longitudinal change in executive control but not memory. Int J Geriatr Psychiatry 27, 89-96.
27. K̈ohler S, van Boxtel M, Jolles J, Verhey F (2011) Depressive symptoms and risk for dementia: A 9-year follow-up of the Maastricht Aging Study. Am J Geriatr Psychiatry 19, 902-905.
28. Panza F, D'Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, Frisardi V, Scapicchio P, Chiloiro R, Scafato E, Gandin C, Vendemiale G, Capurso A, Solfrizzi V (2009) Temporal relationship between depressive symptoms and cognitive impairment: The Italian Longitudinal Study on Aging. J Alzheimers Dis 17, 899-911.
29. Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES Jr, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M (2010) National Institutes of Health Stateof-the-Science Conference statement: Preventing Alzheimer disease and cognitive decline. Ann Intern Med 153, 176-181.
30. Beekly DL, Ramos EM, van Belle G, Deitrich W, Clark AD, Jacka ME, Kukull WA, NIA-Alzheimer's Disease Centers (2004) The National Alzheimer's Coordinating Center (NACC) Database: An Alzheimer disease database. Alzheimer Dis Assoc Disord 18, 270-277. (Pubitemid 40076162)
31. Rosenberg PB, Mielke MM, Appleby B, Oh E, Leoutsakos JM, Lyketsos CG (2011) Neuropsychiatric symptoms in MCI subtypes: The importance of executive dysfunction. Int J Geriatr Psychiatry 26, 364-372.
32. Frazer A (2001) Serotonergic and noradrenergic reuptake inhibitors: Prediction of clinical effects from in vitro potencies. J Clin Psychiatry 62, 16-23. (Pubitemid 32578703)
33. Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, Tangalos EG, Ivnik RJ, Rocca WA, Petersen RC (2012) The incidence of MCI differs by subtype and is higher in men: The Mayo Clinic Study of Aging. Neurology 78, 342-351.
34. Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C, Medical Research Council Cognitive Function Ageing Study (2008) Two-year progression from mild cognitive impairment to dementia: To what extent do different definitions agree? J Am Geriatr Soc 56, 1424-1433.
35. Weuve J, McQueen MB, Blacker D (2012) The AlzRisk Database. Alzheimer Research Forum, http://www.alzforum. org. Accessed 8 March 2012.
36. Li G, Wang LY, Shofer JB, Thompson ML, Peskind ER, McCormickW, Bowen JD, Crane PK, LarsonEB(2011) Temporal relationship between depression and dementia: Findings from a large community-based 15-year follow-up study. Arch Gen Psychiatry 68, 970-977.
37. Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC (2009) Alzheimer's Disease Neuroimaging Initiative. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease. Brain 132(Pt 5), 1355-1365.
38. Leonard BE (2007) Inflammation, depression and dementia: Are they connected? Neurochem Res 32, 1749-1756. (Pubitemid 47428863)
39. Korczyn AD, Halperin I (2009) Depression and dementia. J Neurol Sci 283, 139-142.
40. Aizenstein HJ, Andreescu C, Edelman KL, Cochran JL, Price J, Butters MA, Karp J, Patel M, Reynolds CF 3rd (2011) fMRI correlates of white matter hyperintensities in late-life depression. Am J Psychiatry 168, 1075-1082.
41. McClungCA(2011) Circadian rhythms and mood regulation: Insights from pre-clinical models. Eur Neuropsychopharmacol 21(Suppl 4), S683-S693.
42. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM (2009) Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005-1007.